Provider review
Mojoon review
By Derek Olsson ·
Its own three pages disagree on which states it serves
The only Mandarin- and Cantonese-first GLP-1 platform we found: semaglutide runs $350 to $520 a course, tirzepatide $390 to $490 a month. Three of its own pages give three different answers about which states it serves.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
Mojoon's tirzepatide pricing is clearly itemized by dose, but check your specific state before enrolling — its own homepage, About page, and FAQ each state a different list of excluded states, and none of the three agree with each other. Its semaglutide page also headlines itself as "FDA-approved" while its own body text says the medication is compounded and non-FDA-approved.
Mojoon isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.
Alternatives to Mojoon
Other providers we work with. Compare prices before you sign up anywhere.
Live VitalPartner
$297 per ten-week protocol
MadeMedPartner
$179 per 30 days + consult
HealthRXPartner
$165/mo ($99 first month)
Who it is for, and who it is not
A good fit if
- You want bilingual Mandarin/Cantonese support — the only platform found offering it in this category
- You want tirzepatide priced clearly by dose tier ($390–$490/month)
- You want a domain-matched LegitScript seal
Look elsewhere if
- You need certainty your state is covered — Mojoon's own pages disagree with each other on which states are excluded
- You're relying on the "FDA-Approved" headline on its semaglutide page — its own body text says the medication is compounded and non-FDA-approved
- You want a named physician — none is disclosed anywhere
What it actually costs
What they advertise
Compounded semaglutide runs $350–$520 per course on its own site's own pricing page.
What you actually pay, month to month
Tirzepatide is priced by dose: $390/month for 2.5–10mg, rising to $490/month for 12.5–15mg.
The commitment trap
Mojoon's semaglutide page shows a $350–$520 course range that its own FAQ separately describes with a $450/month example, without clearly stating how long a "course" runs.
Prices come from Mojoon's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
Compare the total cost, including fees and any minimum commitment. Here is what Mojoon bundles in, and what it does not.
Clinician consult
Not published
Bloodwork / labs
Not published
Follow-ups and dose changes
No cadence published
Human support
Bilingual Mandarin/Cantonese support
Injection supplies
Shipped via an FDA-registered 503A/503B compounding pharmacy
Shipping
No timeline published
Pharmacy, labs and oversight
The pharmacy
Described only as "an FDA-registered 503A/503B compounding pharmacy," VIPPS/NABP- and URAC-accredited; not individually named.
Oversight
No cadence published.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
Contradictory across Mojoon's own pages: its homepage claims 48 states (excluding New Mexico and Mississippi), its About page's printed list actually covers all 50 states plus DC, and a separate, visibly stale FAQ names a third exclusion list entirely.
The honest cons
The part they would rather you skipped
Mojoon's own homepage, About page, and FAQ each state a different list of which states it serves — and its semaglutide page headlines "FDA-Approved" while its own body text says the medication is a compounded, non-FDA-approved version of Wegovy/Ozempic.
- Three of its own pages disagree with each other on state coverage
- Semaglutide page headline says "FDA-Approved" while its own body text says compounded/non-FDA-approved
- No physician named anywhere
- FAQ page carries visibly stale 2023-dated content that contradicts the site's current live scope
Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.
Similar providers
- MultiMedRxThe recurring total still needs a written quoteRead review →
- Modern Age$1,500 for the initial assessmentRead review →
- MyDietDocCurrent price remains unconfirmedRead review →
- Mochi HealthAbout $139–$178 sema / $169–$278 tirz monthly, cashRead review →
- MyFastRx$139/mo semaglutide; $199/mo tirzepatideRead review →
- Mixx Health and WellnessDrug-specific monthly total not establishedRead review →
Side by side: our semaglutide provider ranking · Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Provider offers and terms are based on Mojoon's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on Mojoon's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.